BCL2L11 and pancreatic acinar cell carcinoma: Of note, the one patient who achieved a partial response (pancreatic acinar cell carcinoma with KANK4-RAF1 fusion identified by clinical-grade next generation sequencing) demonstrated the most dramatic change in BIM expression (Figure 3, Supplementary Table 5).